Projected Peripheral Defocus Using a Wearable Device
- Conditions
- Myopia
- Registration Number
- NCT04415684
- Lead Sponsor
- Kubota Vision Inc.
- Brief Summary
Acucela Inc. intends to develop a medical device to significantly halt or reverse myopic progression, which is a significant public health concern across the world, especially in Asian demographics. Acucela is working towards a spectacle-like device (eSPECs), which will have a clear zone for unimpeded central visual tasks and a periphery that provides defocus in order to alter retinal physiology leading to myopia regulation. This study will establish the changes seen during a proof-of-concept that projected defocus in the periphery utilizing a wearable device will stimulate physiological changes similar to those in the literature.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 26
- Spherical equivalent +2.00 to -4.00 diopters
- Refractive cylinder ≤ 0.75 diopters
- Visual acuity 20/20 -3 or better
- Pregnant or lactating
- Active ocular infection
- History of dry eye, strabismus, or amblyopia
- Previous or planned ocular surgery
- Use of medication known to affect vision or accommodation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Choroidal thickness (CT) 1 hour Change in CT from baseline in the test eye vs. control eye
Axial length (AL) 1 hour Change in AL from baseline in the test eye vs. control eye
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Manhattan Vision Associates/institute of Vision Research
🇺🇸New York, New York, United States
Manhattan Vision Associates/institute of Vision Research🇺🇸New York, New York, United States